320 related articles for article (PubMed ID: 24089526)
1. Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
Pei S; Minhajuddin M; Callahan KP; Balys M; Ashton JM; Neering SJ; Lagadinou ED; Corbett C; Ye H; Liesveld JL; O'Dwyer KM; Li Z; Shi L; Greninger P; Settleman J; Benes C; Hagen FK; Munger J; Crooks PA; Becker MW; Jordan CT
J Biol Chem; 2013 Nov; 288(47):33542-33558. PubMed ID: 24089526
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Pei S; Minhajuddin M; D'Alessandro A; Nemkov T; Stevens BM; Adane B; Khan N; Hagen FK; Yadav VK; De S; Ashton JM; Hansen KC; Gutman JA; Pollyea DA; Crooks PA; Smith C; Jordan CT
J Biol Chem; 2016 Oct; 291(42):21984-22000. PubMed ID: 27573247
[TBL] [Abstract][Full Text] [Related]
4. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
Hassane DC; Guzman ML; Corbett C; Li X; Abboud R; Young F; Liesveld JL; Carroll M; Jordan CT
Blood; 2008 Jun; 111(12):5654-62. PubMed ID: 18305216
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
6. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
[TBL] [Abstract][Full Text] [Related]
7. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
8. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Neelakantan S; Li X; Corbett CA; Hassane DC; Becker MW; Bennett JM; Sullivan E; Lachowicz JL; Vaughan A; Sweeney CJ; Matthews W; Carroll M; Liesveld JL; Crooks PA; Jordan CT
Blood; 2007 Dec; 110(13):4427-35. PubMed ID: 17804695
[TBL] [Abstract][Full Text] [Related]
9. Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia.
Darwish NHE; Sudha T; Godugu K; Bharali DJ; Elbaz O; El-Ghaffar HAA; Azmy E; Anber N; Mousa SA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31163672
[TBL] [Abstract][Full Text] [Related]
10. Construction of Genetically Encoded Biosensors to Monitor Subcellular Compartment-Specific Glutathione Response to Chemotherapeutic Drugs in Acute Myeloid Leukemia Cells.
Abbas G; Cui M; Wang D; Li M; Zhang XE
Anal Chem; 2023 Feb; 95(5):2838-2847. PubMed ID: 36701391
[TBL] [Abstract][Full Text] [Related]
11. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
Capala ME; Vellenga E; Schuringa JJ
PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
[TBL] [Abstract][Full Text] [Related]
12. Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress.
Siitonen T; Alaruikka P; Mäntymaa P; Savolainen ER; Kavanagh TJ; Krejsa CM; Franklin CC; Kinnula V; Koistinen P
Ann Oncol; 1999 Nov; 10(11):1361-7. PubMed ID: 10631466
[TBL] [Abstract][Full Text] [Related]
13. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
14. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
15. BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.
Piya S; Mu H; Bhattacharya S; Lorenzi PL; Davis RE; McQueen T; Ruvolo V; Baran N; Wang Z; Qian Y; Crews CM; Konopleva M; Ishizawa J; You MJ; Kantarjian H; Andreeff M; Borthakur G
J Clin Invest; 2019 May; 129(5):1878-1894. PubMed ID: 30829648
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
Raaijmakers MH; de Grouw EP; van der Reijden BA; de Witte TJ; Jansen JH; Raymakers RA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3452-8. PubMed ID: 16740770
[TBL] [Abstract][Full Text] [Related]
17. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
[TBL] [Abstract][Full Text] [Related]
18. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.
Guzman ML; Neering SJ; Upchurch D; Grimes B; Howard DS; Rizzieri DA; Luger SM; Jordan CT
Blood; 2001 Oct; 98(8):2301-7. PubMed ID: 11588023
[TBL] [Abstract][Full Text] [Related]
20. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase.
Wang X; Gao M; Zhang J; Ma Y; Qu W; Liang J; Wu H; Wen H
Redox Biol; 2019 Jun; 24():101153. PubMed ID: 30909158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
